Methyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate

Catalog No.: 
ACAHON167
CAS No.: 
936637-97-7
Molecular Formula: 
C10H8N2O3
Molecular Weight: 
204.18
Methyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$91.00In stockIn stock
1g98%$346.00In stockIn stock
5g98%$1678.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate
IUPAC Namemethyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate
MDL No.MFCD16987698
Molecular FormulaC10H8N2O3
Molecular Weight204.18
SMILESO=C(C1=C2C=C(C=O)C=CN2N=C1)OC
InChI KeyAHPBXOYVKDTSQN-UHFFFAOYSA-N
SynonymMethyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate;5-formylpyrazolo[1,5-a]pyridine-3-carboxylate;methyl 5-formylH-pyrazolo[1,5-a]pyridine-3-carboxylate;Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 5-formyl-, methyl ester
CAS No.936637-97-7
PubChem CID82396726

Synthetic Route by SureRoute

1. ACAHON167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGJVW901 route compound structure diagram
    ACGJVW901474432-56-9In Stock
  2. Then
  3. ACAHON167 route product structure diagram
    ACAHON167936637-97-7In Stock
Inquiry

2. ACAHON167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTQGW872 route compound structure diagram
    ACTQGW8721352897-20-1In Stock
  4. Then
  5. ACAHON167 route product structure diagram
    ACAHON167936637-97-7In Stock
Inquiry

3. ACAHON167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAHON167 route product structure diagram
    ACAHON167936637-97-7In Stock
Inquiry

Comments (0)